Clinical Trials in Colorado

Showing 8921-8940 of 18,143 trials

Study of Nebulized Ampion for the Treatment of Adult COVID-19 Patients With Respiratory Distress

NCT04606784

This is a Phase 1 randomized study to evaluate the safety, tolerability and efficacy of nebulized Ampion in improving the clinical course and outcomes of patients hospitalized with COVID-19 infection who have respiratory distress.

Covid19

Ampio Pharmaceuticals. Inc.40 participantsStarted Oct 2020

Colorado Springs, Colorado, United States

TERMINATEDPhase 450 miles

A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma

NCT04195958

This study will assess the effect of omalizumab on exercise capacity, physical activity, and sleep quality after 24 weeks of treatment in participants with moderate to severe allergic asthma. Exercise capacity will be assessed using cardiopulmonary exercise testing (CPET). Physical activity and sleep quality will be assessed with a wearable physical activity and sleep monitor. The study will consist of a 4-week screening period, a 24-week treatment period, and a 4-week safety follow-up. Approximately 60 participants will be enrolled, and omalizumab will be dosed according to the approved United States Package Insert (USPI) dosing table.

Moderate-to-severe Allergic Asthma

Genentech, Inc.3 participantsStarted Nov 2020

Rolling Hills Estates, California, United States • Denver, Colorado, United States • Pembroke Pines, Florida, United States +9 more locations

Study of Nebulized Ampion for the Treatment of Adult COVID-19 Patients With Respiratory Distress

A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma

Find Trials by Condition in Colorado

Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

Adaptive COVID-19 Treatment Trial (ACTT)

A Pharmacokinetic, Pharmacodynamic, Safety and Tolerability Study of CERC-006 in Adults With Complex Lymphatic Malformations

Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects

Observational Study in Cystic Fibrosis Patients Using TOBI® PODHALER® or Other FDA Approved Inhaled Antipseudomonal Antibacterial Drugs

Mesenchymal Stem Cell Therapy for Knee Osteoarthritis

Fetal Pulse Oximetry Trial (FOX)

A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults

COVID-19 Progression in End-Stage Kidney Disease

A Study of Opaganib in Coronavirus Disease 2019 Pneumonia

A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis

Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.

CMF Bone Stimulation as Adjunct to Surgical Treatment of Ankle Fractures

A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

A Safety Study of LY3462817 and LY3509754 in Participants With Psoriasis

HTX-011 Administration Study in Planned Caesarean Section Procedure

Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease

Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis